55 results
Page 3 of 3
424B1
5jztc ae3k6
31 Jan 14
Prospectus with pricing info
12:00am
424B3
v4rjgv1igx5hb atn
10 Jan 14
Prospectus supplement
12:00am
8-K
c8f0ovpt3gqo
10 Jan 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-14.1
eemqf94dfvo ilphs9fh
7 Jan 14
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
424B3
502quzo3uyziqrorp2
19 Dec 13
Prospectus supplement
12:00am
8-K
EX-99.1
c73yfvti
9 Dec 13
Intra-Cellular Therapies Announces Positive Topline Phase II Clinical Results of ITI-007 for the Treatment of Schizophrenia
12:00am
8-K/A
EX-10.1.1
kkgbyqlo3j08n29
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
p2r 5qvu8sux
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-10.2
p39grrwkrm0uctg7jr
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
S-1
bnxcm9wz7vqb
18 Sep 13
IPO registration
12:00am
8-K
v83za
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-10.2
i1t48ojt826c82nnscig
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-10.1.1
zl8ygyj4r8uvgr iy
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-2.1
ibm92a553t8h
29 Aug 13
Entry into a Material Definitive Agreement
12:00am
10-K
EX-14.1
s5rk6
16 Jul 13
Annual report
12:00am